Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Incorporating Tumor Cavitation into Response Assessment
Tue, 01/20/2009 - 21:29
Author
Howard (Jack) West, MD, Vice President of Clinical Development at Summit Therapeutics, Founder and Past Board President, GRACE

As I described in a post last year, one of the common features of angiogensis inhibitors is that lesion often cavitate, shrinking not only from the outside in, but hollowing out and dying from the inside out. One of the concerns has been that cavitating lesions may be at higher risk for bleeding, but the work I described in the prior post suggested no clearly increased risk of severe bleeding complications among patients who develop tumor cavitation on anti-angiogenic agents. But another issue is that tumor cavitation may be a relevant measure of response that is being missed by out current systems of measuring response by only assessing the outer dimensions of a tumor.

Investigators in Ontario, Canada looked at this issue by assessing the frequency of this cavitary response in a couple of recent trials they ran through the National Cancer Institute of Canada (abstract here). This report looked retrospectively at 33 patients who received doublet chemo with an antiangiogenic agent (in this case, the oral VEGF inhibitor cedirinib, also known as AZD-2171) and found that 8 (24%) experienced tumor cavitation during treatment. This wasn't seen in any of the 18 patients treated with chemo alone on another trial of chemo alone that ran over a similar time line in Canada (and it's rarely seen with chemo alone in general).

A typical situation is shown in the figure below, in which a mass doesn't change outer dimensions, but it hollows out early in treatment, then progresses by the filling in of the center of the tumor.

Trajectory of Response by Cavitation

It's probably very relevant that the overall volume of viable cancer has decreased substantially early in treatment, but that response isn't captured by our current system. Nor is the clear increase in tumor bulk as the cancer grows internally, since outer dimensions again don't change.

The investigators tested how many patients would have experienced a change in their official response if an alternative definition of response was used in which tumor measurements included not just outer dimensions but subtracted the hollowed out portion of any cavitating lesion. And progression would be defined not only by outer dimensions but by the filling in of cavitation:

Redefining response by Cavitation

When they did tumor measurements by both the current standard (outer dimensions only) and the new alternative that incorporates measurement of the tumor cavity, a few of the patients had differences in their response assessments, going from stable disease to a partial response, or from stable disease to progression. They started with small numbers of patients and just assessed these issues retrospectively, so you really couldn't say anything definitive. But it was interesting to see that the current system probably misses some meaningful anti-angiogenesis-induced responses and can keep people on an ineffective therapy for too long while they progress within the stable shell of a tumor.

The invstigators suggested that this new technique needs to be tested in trials moving forward, and I agree. But even this early work could be useful

Next Previous link

Previous PostNext Post

Related Content

Image
Terapias Dirigidas de Cáncer de Pulmón 2023
Video
En este foro anual de pacientes en vivo, los principales oncólogos torácicos de todo el mundo discuten temas relevantes para los objetivos del cáncer de pulmón, así como mutaciones raras. En esta serie de videos los Doctores Fernando Diaz, Luis Raez, Luis Corrales, Estelamari Rodriguez y Alberto Chiappori presentan el Panel de Discusión donde hablan sobre temas relevantes del cáncer de pulmón. 
Image
Terapias Dirigidas de Cáncer de Pulmón 2023
Video
En este foro anual de pacientes en vivo, los principales oncólogos torácicos de todo el mundo discuten temas relevantes para los objetivos del cáncer de pulmón, así como mutaciones raras. En esta serie de videos los Doctores Fernando Diaz, Luis Raez, Luis Corrales, Estelamari Rodriguez y Alberto Chiappori presentan el Panel de Discusión donde hablan sobre temas relevantes del cáncer de pulmón. 
Image
Targeted Therapies Forum presented in English
Video
This series includes videos from the breakout sessions presented by Dr. Stephen Liu, including the following topics: Safety and Toxicity of Selpercatinib Versus Pralsetinib The Future of RET+ NSCLC Treatment NTRK+ NSCLC: Treatment Options and Side Effects NRG1 Fusions: Treatment Options To watch the complete playlist click here.

Forum Discussions

Stan - Thank you once again for your kind words.  Thank you as well for your donation.  As you know, your donation helps us to exist and continue to fulfill our...

Hi Stan, It's good to hear your voice and know your cheesecakes are still making the rounds.  Though I'm sure startling, I imagine some of those little pockets of the house...

Hi Rutbats,  Welcome to GRACE and thanks for the kind words. 

 

We can't say what you should or shouldn't do and I can't say why your RA doc made their...

Thank you very much for your quick answer, Janine.

I have an appointment with a pulmonologist in 10 days. I will summarize the conversation with him here, so that other people...

Glad to know you're moving forward with a pulmonologist.  The more you know the better the conversation with your pulmonologist.  Remember you can help your docs know what level their conversation...

Hi Terry, Welcome to Grace. 

I saw this exact post somewhere else months back and the only response was to a lab.  I hope that doesn't happen here, we don't allow...

Recent Comments

JOIN THE CONVERSATION
Hi Stan, It's good to hear…
By JanineT GRACE … on Fri, 12/01/2023 - 07:14
Thank you Stan, for your kind words.
By dbrock on Thu, 11/30/2023 - 11:55
Glad to know you're moving…
By JanineT GRACE … on Mon, 11/27/2023 - 11:27
Thank you very much for your…
By rutbats on Mon, 11/27/2023 - 08:07